• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对新冠病毒的兽用疫苗:首款用于动物的新冠疫苗。

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals.

作者信息

Chavda Vivek P, Feehan Jack, Apostolopoulos Vasso

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad-380008, Gujarat, India.

Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.

出版信息

Vaccines (Basel). 2021 Jun 10;9(6):631. doi: 10.3390/vaccines9060631.

DOI:10.3390/vaccines9060631
PMID:34200587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8228738/
Abstract

As coronaviruses have a wide range of host species, many animals harbor these pathogens, however only a handful of them become severely infected [...].

摘要

由于冠状病毒具有广泛的宿主物种,许多动物都携带这些病原体,然而只有少数动物会受到严重感染[...]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5b/8228738/0d72cb733863/vaccines-09-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5b/8228738/0d72cb733863/vaccines-09-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5b/8228738/0d72cb733863/vaccines-09-00631-g001.jpg

相似文献

1
A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals.一种针对新冠病毒的兽用疫苗:首款用于动物的新冠疫苗。
Vaccines (Basel). 2021 Jun 10;9(6):631. doi: 10.3390/vaccines9060631.
2
SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management.严重急性呼吸综合征冠状病毒2:从结构到病理学、宿主免疫反应及治疗管理
Microorganisms. 2020 Sep 24;8(10):1468. doi: 10.3390/microorganisms8101468.
3
Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans.牛和猪呼吸道冠状病毒与人类 SARS-CoV-2 在动物宿主物种中的比较发病机制。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01355-20.
4
Targets and strategies for vaccine development against SARS-CoV-2.针对 SARS-CoV-2 的疫苗研发的靶点和策略。
Biomed Pharmacother. 2021 May;137:111254. doi: 10.1016/j.biopha.2021.111254. Epub 2021 Jan 28.
5
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告:评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
6
G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2.人冠状病毒包括新冠病毒中存在G-四链体。
Front Microbiol. 2020 Oct 23;11:567317. doi: 10.3389/fmicb.2020.567317. eCollection 2020.
7
Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals.人类和动物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗原的抗体反应。
Vaccines (Basel). 2020 Nov 16;8(4):684. doi: 10.3390/vaccines8040684.
8
Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.基于 SARS-CoV-2 核衣壳蛋白的免疫信息学分析与 COVID-19 疫苗靶点的鉴定
Front Immunol. 2020 Oct 28;11:587615. doi: 10.3389/fimmu.2020.587615. eCollection 2020.
9
Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.了解新型冠状病毒肺炎的动态;对治疗干预、疫苗研发和行动管制的影响。
Br J Biomed Sci. 2020 Oct;77(4):168-184. doi: 10.1080/09674845.2020.1826136.
10
[Medically relevant aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animals].[动物中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的医学相关方面]
Orv Hetil. 2021 Jan 31;162(5):163-170. doi: 10.1556/650.2021.32117.

引用本文的文献

1
Safety and immunogenicity of a SARS-CoV-2 mRNA vaccine (SYS6006) in minks, cats, blue foxes, and raccoon dogs.在水貂、猫、蓝狐和貉中 SARS-CoV-2 mRNA 疫苗(SYS6006)的安全性和免疫原性。
Front Cell Infect Microbiol. 2024 Sep 19;14:1468775. doi: 10.3389/fcimb.2024.1468775. eCollection 2024.
2
The reverse zoonotic potential of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的反向人畜共患病潜力。
Heliyon. 2024 Jun 13;10(12):e33040. doi: 10.1016/j.heliyon.2024.e33040. eCollection 2024 Jun 30.
3
Breaking the Barrier: SARS-CoV-2 Infections in Wild and Companion Animals and Their Implications for Public Health.

本文引用的文献

1
COVID-19 in Human, Animal, and Environment: A Review.人类、动物和环境中的新冠病毒:综述
Front Vet Sci. 2020 Sep 4;7:578. doi: 10.3389/fvets.2020.00578. eCollection 2020.
突破壁垒:野生和伴侣动物中的 SARS-CoV-2 感染及其对公共卫生的影响。
Viruses. 2024 Jun 13;16(6):956. doi: 10.3390/v16060956.
4
Perspectives on SARS-CoV-2 Cases in Zoological Institutions.动物园机构中新型冠状病毒肺炎病例的观点
Vet Sci. 2024 Feb 7;11(2):78. doi: 10.3390/vetsci11020078.
5
Advancements in veterinary medicine: the use of Flowgy for nasal airflow simulation and surgical predictions in big felids (a case study in lions).兽医学的进展:Flowgy在大型猫科动物鼻腔气流模拟和手术预测中的应用(以狮子为例的案例研究)
Front Vet Sci. 2024 Jan 24;10:1181036. doi: 10.3389/fvets.2023.1181036. eCollection 2023.
6
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants.用于诊断新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的传统和新型诊断工具
Vaccines (Basel). 2023 Feb 6;11(2):374. doi: 10.3390/vaccines11020374.
7
Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta).实验室恒河猴(Macaca mulatta)接种 SARS-CoV-2 疫苗的监测和免疫原性。
Sci Rep. 2023 Feb 25;13(1):3274. doi: 10.1038/s41598-023-30473-7.
8
Co-infection associated with SARS-CoV-2 and their management.与严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)相关的合并感染及其管理。
Future Sci OA. 2023 Feb 3;8(9):FSO819. doi: 10.2144/fsoa-2022-0011. eCollection 2022 Oct.
9
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.用于COVID-19治疗的康复期血浆(高免疫球蛋白):最新情况
Process Biochem. 2023 Apr;127:66-81. doi: 10.1016/j.procbio.2023.01.018. Epub 2023 Jan 31.
10
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management.严重急性呼吸综合征冠状病毒2型奥密克戎变种:印度对疫苗接种及管理的看法
Vaccines (Basel). 2023 Jan 11;11(1):160. doi: 10.3390/vaccines11010160.